Microluma’s Scientific Advisory Board is composed of faculty members from Universidad Autónoma de Madrid (UAM), a leading public research university in Spain, under a formal collaboration agreement that supports the co-development and validation of next-generation microscopy and AI-driven analytical technologies.
The Board brings together expertise in molecular and cellular biology, oncology and translational drug discovery, with extensive experience in advanced microscopy, immunofluorescence-based cellular phenotyping, toxicological profiling and quantitative analysis of cell death and organelle dynamics.
This collaboration enables rigorous real-world scientific testing of Microluma’s beta-stage platforms within academic and translational research environments, ensuring alignment with the experimental needs of biomedical laboratories while establishing a robust framework for future Spanish and European public–private R&D funding initiatives.